List of Tables
Table 1. Global Cyclic Peptide Compounds Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cyclic Peptide Compounds Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cyclic Peptide Compounds Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cyclic Peptide Compounds Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cyclic Peptide Compounds Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Cyclic Peptide Compounds Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Cyclic Peptide Compounds Sales by Region (2020-2025) & (Tons)
Table 8. Global Cyclic Peptide Compounds Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Cyclic Peptide Compounds Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Cyclic Peptide Compounds Production by Region (2020-2025) & (Tons)
Table 12. Global Cyclic Peptide Compounds Production by Region (2026-2031) & (Tons)
Table 13. Global Cyclic Peptide Compounds Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Cyclic Peptide Compounds Sales Share by Manufacturers (2020-2025)
Table 15. Global Cyclic Peptide Compounds Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Cyclic Peptide Compounds Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Cyclic Peptide Compounds by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclic Peptide Compounds as of 2024)
Table 19. Global Cyclic Peptide Compounds Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Cyclic Peptide Compounds Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 21. Key Manufacturers Cyclic Peptide Compounds Manufacturing Base and Headquarters
Table 22. Global Cyclic Peptide Compounds Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Cyclic Peptide Compounds Sales by Type (2020-2025) & (Tons)
Table 26. Global Cyclic Peptide Compounds Sales by Type (2026-2031) & (Tons)
Table 27. Global Cyclic Peptide Compounds Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Cyclic Peptide Compounds Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Cyclic Peptide Compounds ASP by Type (2020-2031) & (US$/kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Cyclic Peptide Compounds Sales by Application (2020-2025) & (Tons)
Table 32. Global Cyclic Peptide Compounds Sales by Application (2026-2031) & (Tons)
Table 33. Cyclic Peptide Compounds High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Cyclic Peptide Compounds Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Cyclic Peptide Compounds Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Cyclic Peptide Compounds ASP by Application (2020-2031) & (US$/kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Cyclic Peptide Compounds Growth Accelerators and Market Barriers
Table 40. North America Cyclic Peptide Compounds Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Cyclic Peptide Compounds Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Cyclic Peptide Compounds Growth Accelerators and Market Barriers
Table 43. Europe Cyclic Peptide Compounds Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Cyclic Peptide Compounds Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Cyclic Peptide Compounds Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Cyclic Peptide Compounds Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Cyclic Peptide Compounds Growth Accelerators and Market Barriers
Table 48. Southeast Asia Cyclic Peptide Compounds Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Cyclic Peptide Compounds Investment Opportunities and Key Challenges
Table 50. Central and South America Cyclic Peptide Compounds Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Cyclic Peptide Compounds Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Cyclic Peptide Compounds Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Bicycle Therapeutics Corporation Information
Table 54. Bicycle Therapeutics Description and Major Businesses
Table 55. Bicycle Therapeutics Product Models, Descriptions and Specifications
Table 56. Bicycle Therapeutics Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 57. Bicycle Therapeutics Sales Value Proportion by Product in 2024
Table 58. Bicycle Therapeutics Sales Value Proportion by Application in 2024
Table 59. Bicycle Therapeutics Sales Value Proportion by Geographic Area in 2024
Table 60. Bicycle Therapeutics Cyclic Peptide Compounds SWOT Analysis
Table 61. Bicycle Therapeutics Recent Developments
Table 62. Apellis Pharmaceuticals Corporation Information
Table 63. Apellis Pharmaceuticals Description and Major Businesses
Table 64. Apellis Pharmaceuticals Product Models, Descriptions and Specifications
Table 65. Apellis Pharmaceuticals Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 66. Apellis Pharmaceuticals Sales Value Proportion by Product in 2024
Table 67. Apellis Pharmaceuticals Sales Value Proportion by Application in 2024
Table 68. Apellis Pharmaceuticals Sales Value Proportion by Geographic Area in 2024
Table 69. Apellis Pharmaceuticals Cyclic Peptide Compounds SWOT Analysis
Table 70. Apellis Pharmaceuticals Recent Developments
Table 71. Merck Corporation Information
Table 72. Merck Description and Major Businesses
Table 73. Merck Product Models, Descriptions and Specifications
Table 74. Merck Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. Merck Sales Value Proportion by Product in 2024
Table 76. Merck Sales Value Proportion by Application in 2024
Table 77. Merck Sales Value Proportion by Geographic Area in 2024
Table 78. Merck Cyclic Peptide Compounds SWOT Analysis
Table 79. Merck Recent Developments
Table 80. Bachem Corporation Information
Table 81. Bachem Description and Major Businesses
Table 82. Bachem Product Models, Descriptions and Specifications
Table 83. Bachem Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 84. Bachem Sales Value Proportion by Product in 2024
Table 85. Bachem Sales Value Proportion by Application in 2024
Table 86. Bachem Sales Value Proportion by Geographic Area in 2024
Table 87. Bachem Cyclic Peptide Compounds SWOT Analysis
Table 88. Bachem Recent Developments
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Product Models, Descriptions and Specifications
Table 92. Novartis Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 93. Novartis Sales Value Proportion by Product in 2024
Table 94. Novartis Sales Value Proportion by Application in 2024
Table 95. Novartis Sales Value Proportion by Geographic Area in 2024
Table 96. Novartis Cyclic Peptide Compounds SWOT Analysis
Table 97. Novartis Recent Developments
Table 98. Roche (Chugai Pharmabody Research) Corporation Information
Table 99. Roche (Chugai Pharmabody Research) Description and Major Businesses
Table 100. Roche (Chugai Pharmabody Research) Product Models, Descriptions and Specifications
Table 101. Roche (Chugai Pharmabody Research) Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 102. Roche (Chugai Pharmabody Research) Recent Developments
Table 103. Biopharma PEG Scientific Corporation Information
Table 104. Biopharma PEG Scientific Description and Major Businesses
Table 105. Biopharma PEG Scientific Product Models, Descriptions and Specifications
Table 106. Biopharma PEG Scientific Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 107. Biopharma PEG Scientific Recent Developments
Table 108. Pfizer Corporation Information
Table 109. Pfizer Description and Major Businesses
Table 110. Pfizer Product Models, Descriptions and Specifications
Table 111. Pfizer Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 112. Pfizer Recent Developments
Table 113. AstraZeneca Corporation Information
Table 114. AstraZeneca Description and Major Businesses
Table 115. AstraZeneca Product Models, Descriptions and Specifications
Table 116. AstraZeneca Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 117. AstraZeneca Recent Developments
Table 118. Eli Lilly Corporation Information
Table 119. Eli Lilly Description and Major Businesses
Table 120. Eli Lilly Product Models, Descriptions and Specifications
Table 121. Eli Lilly Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 122. Eli Lilly Recent Developments
Table 123. GenScript Biotech Corporation Information
Table 124. GenScript Biotech Description and Major Businesses
Table 125. GenScript Biotech Product Models, Descriptions and Specifications
Table 126. GenScript Biotech Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 127. GenScript Biotech Recent Developments
Table 128. Key Raw Materials Distribution
Table 129. Raw Materials Key Suppliers
Table 130. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 131. Milestones in Production Technology Evolution
Table 132. Distributors List
Table 133. Market Trends and Market Evolution
Table 134. Market Drivers and Opportunities
Table 135. Market Challenges, Risks, and Restraints
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Cyclic Peptide Compounds Product Picture
Figure 2. Global Cyclic Peptide Compounds Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Natural Cyclic Peptide Product Picture
Figure 4. Synthetic Cyclic Peptide Product Picture
Figure 5. Global Cyclic Peptide Compounds Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Biopharmaceutical
Figure 7. Environmental Protection
Figure 8. Scientific Research
Figure 9. Others
Figure 10. Cyclic Peptide Compounds Report Years Considered
Figure 11. Global Cyclic Peptide Compounds Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 13. Global Cyclic Peptide Compounds Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Cyclic Peptide Compounds Revenue Market Share by Region (2020-2031)
Figure 15. Global Cyclic Peptide Compounds Sales (2020-2031) & (Tons)
Figure 16. Global Cyclic Peptide Compounds Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Cyclic Peptide Compounds Sales Market Share by Region (2020-2031)
Figure 18. Global Cyclic Peptide Compounds Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Cyclic Peptide Compounds Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Cyclic Peptide Compounds Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Cyclic Peptide Compounds Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. Cyclic Peptide Compounds Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. Cyclic Peptide Compounds Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. Cyclic Peptide Compounds Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers Cyclic Peptide Compounds Sales Volume Market Share in 2024
Figure 27. Global Cyclic Peptide Compounds Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Natural Cyclic Peptide Revenue Market Share by Manufacturer in 2024
Figure 30. Synthetic Cyclic Peptide Revenue Market Share by Manufacturer in 2024
Figure 31. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 32. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 33. Global Cyclic Peptide Compounds Sales Market Share by Type (2020-2031)
Figure 34. Global Cyclic Peptide Compounds Revenue Market Share by Type (2020-2031)
Figure 35. Global Cyclic Peptide Compounds Sales Market Share by Application (2020-2031)
Figure 36. Global Cyclic Peptide Compounds Revenue Market Share by Application (2020-2031)
Figure 37. North America Cyclic Peptide Compounds Sales YoY (2020-2031) & (Tons)
Figure 38. North America Cyclic Peptide Compounds Revenue YoY (2020-2031) & (US$ Million)
Figure 39. North America Top 5 Manufacturers Cyclic Peptide Compounds Sales Revenue (US$ Million) in 2024
Figure 40. North America Cyclic Peptide Compounds Sales Volume (Tons) by Type (2020- 2031)
Figure 41. North America Cyclic Peptide Compounds Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 42. North America Cyclic Peptide Compounds Sales Volume (Tons) by Application (2020-2031)
Figure 43. North America Cyclic Peptide Compounds Sales Revenue (US$ Million) by Application (2020-2031)
Figure 44. US Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 45. Canada Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 46. Mexico Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 47. Europe Cyclic Peptide Compounds Sales YoY (2020-2031) & (Tons)
Figure 48. Europe Cyclic Peptide Compounds Revenue YoY (2020-2031) & (US$ Million)
Figure 49. Europe Top 5 Manufacturers Cyclic Peptide Compounds Sales Revenue (US$ Million) in 2024
Figure 50. Europe Cyclic Peptide Compounds Sales Volume (Tons) by Type (2020-2031)
Figure 51. Europe Cyclic Peptide Compounds Sales Revenue (US$ Million) by Type (2020-2031)
Figure 52. Europe Cyclic Peptide Compounds Sales Volume (Tons) by Application (2020-2031)
Figure 53. Europe Cyclic Peptide Compounds Sales Revenue (US$ Million) by Application (2020-2031)
Figure 54. Germany Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 55. France Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 56. U.K. Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 57. Italy Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 58. Russia Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Cyclic Peptide Compounds Sales YoY (2020-2031) & (Tons)
Figure 60. Asia-Pacific Cyclic Peptide Compounds Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Asia-Pacific Top 8 Manufacturers Cyclic Peptide Compounds Sales Revenue (US$ Million) in 2024
Figure 62. Asia-Pacific Cyclic Peptide Compounds Sales Volume (Tons) by Type (2020- 2031)
Figure 63. Asia-Pacific Cyclic Peptide Compounds Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 64. Asia-Pacific Cyclic Peptide Compounds Sales Volume (Tons) by Application (2020-2031)
Figure 65. Asia-Pacific Cyclic Peptide Compounds Sales Revenue (US$ Million) by Application (2020-2031)
Figure 66. Indonesia Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 67. Japan Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 68. South Korea Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 69. China Taiwan Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 70. India Cyclic Peptide Compounds Revenue (2020-2031) & (US$ Million)
Figure 71. Central and South America Cyclic Peptide Compounds Sales YoY (2020-2031) & (Tons)
Figure 72. Central and South America Cyclic Peptide Compounds Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Central and South America Top 5 Manufacturers Cyclic Peptide Compounds Sales Revenue (US$ Million) in 2024
Figure 74. Central and South America Cyclic Peptide Compounds Sales Volume (Tons) by Type (2021-2031)
Figure 75. Central and South America Cyclic Peptide Compounds Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Central and South America Cyclic Peptide Compounds Sales Volume (Tons) by Application (2020-2031)
Figure 77. Central and South America Cyclic Peptide Compounds Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. Brazil Cyclic Peptide Compounds Revenue (2020-2025) & (US$ Million)
Figure 79. Argentina Cyclic Peptide Compounds Revenue (2020-2025) & (US$ Million)
Figure 80. Middle East, and Africa Cyclic Peptide Compounds Sales YoY (2020-2031) & (Tons)
Figure 81. Middle East and Africa Cyclic Peptide Compounds Revenue YoY (2020-2031) & (US$ Million)
Figure 82. Middle East and Africa Top 5 Manufacturers Cyclic Peptide Compounds Sales Revenue (US$ Million) in 2024
Figure 83. Middle East and Africa Cyclic Peptide Compounds Sales Volume (Tons) by Type (2021-2031)
Figure 84. South America Cyclic Peptide Compounds Sales Revenue (US$ Million) by Type (2020-2031)
Figure 85. Middle East and Africa Cyclic Peptide Compounds Sales Volume (Tons) by Application (2020-2031)
Figure 86. Middle East and Africa Cyclic Peptide Compounds Sales Revenue (US$ Million) by Application (2020-2031)
Figure 87. GCC Countries Cyclic Peptide Compounds Revenue (2020-2025) & (US$ Million)
Figure 88. Turkey Cyclic Peptide Compounds Revenue (2020-2025) & (US$ Million)
Figure 89. Egypt Cyclic Peptide Compounds Revenue (2020-2025) & (US$ Million)
Figure 90. South Africa Cyclic Peptide Compounds Revenue (2020-2025) & (US$ Million)
Figure 91. Cyclic Peptide Compounds Industry Chain Mapping
Figure 92. Regional Cyclic Peptide Compounds Manufacturing Base Distribution (%)
Figure 93. Cyclic Peptide Compounds Production Process
Figure 94. Regional Cyclic Peptide Compounds Production Cost Structure
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
